Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases S. Pereyre, C. Laurier Nadalié, C. Bébéar C. Arfeuille, A. Beby-Defaux, B. Berçot, S. Boisset, N. Bourgeois, M.-J. Carles, D. Decré, A.-L. Garand, S.-A. Gibaud, A. Grob, K. Jeannot, M. Kempf, F. Moreau, J. Petitjean-Lecherbonnier, M.-F. Prère, H. Salord, P. Verhoeven S. Pereyre, C. Laurier Nadalié, C. Bébéar C. Arfeuille, A. Beby-Defaux, B. Berçot, S. Boisset, N. Bourgeois, M.-J. Carles, D. Decré, A.-L. Garand, S.-A. Gibaud, A. Grob, K. Jeannot, M. Kempf, F. Moreau, J. Petitjean-Lecherbonnier, M.-F. Prère, H. Salord, P. Verhoeven Clinical Microbiology and Infection Volume 23, Issue 2, Pages 122.e1-122.e7 (February 2017) DOI: 10.1016/j.cmi.2016.10.028 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Fig. 1 Reason for consultation (A) and nature and percentage of genital clinical symptoms (B) in Mycoplasma genitalium– and Trichomonas vaginalis–positive patients. Clinical Microbiology and Infection 2017 23, 122.e1-122.e7DOI: (10.1016/j.cmi.2016.10.028) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions